The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis | Zendy

AI Assistant Blog Pricing

Open Access

The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis

Author(s) -

Anca Trifan

Publication year - 2021

Publication title -

revista medico-chirurgicala

Language(s) - English

Resource type - Journals

ISSN - 2286-2560

DOI - 10.22551/msj.2021.01.08

Subject(s) - hepatocellular carcinoma , propensity score matching , medicine , antiviral therapy , oncology , gastroenterology , virology , virus , chronic hepatitis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.